Mapping European Life Science Investors
Deep-tech VC with a dedicated medical fund.
Exclusive founder network & boutique VC. Active healthtech investor.
University fund (UCLouvain) transforming research into ventures.
Long-standing European life sciences investor.
Partner of VIB, investing in life sciences start-ups.
VC fund of Vetter Pharma family office.
Early-stage investor in technologies revolutionizing healthcare.
Listed investment company with a powerful Life Sciences platform.
Expert-led VC focusing on innovative therapeutics and diagnostics.
Specialist investor focused exclusively on oncology and genetic diseases.
Manager of project/equity funds investing in technology with a health focus.
Incubator/fund by VIB offering funding and strategic support.
Focus on hardware-driven nanotech innovation in health.
Early-stage fund embedded in Central European ecosystem.
Independent advisor and investor focusing on unique VC fund opportunities.
Successful European LS investor, now managing run-off.
Clinical stage Biotherapeutics focused venture fund.
World-leading life science investor (Novo Seeds is the early arm).
Evergreen strategic fund (BioCapital arm).
Deep tech fund with strong science-based health focus.
Generalist early-stage investor with strong health track record.
Nordic investor managing VC funds and corporate venturing.
Deep tech investor with strong health vertical (CEA spinoff).
One of the oldest and most prestigious European VCs.
Key player in European biotech financing.
Early-stage VC investing in health, digital, and tech.
Independent firm dedicated to biotech with "patient benefit" focus.
Digital/Deep Tech VC with strong life sciences arm (PSL Fund).
French public investment bank's dedicated life sciences funds.
Major PE/VC player. 'Andera Life Sciences' invests in innovative therapeutics.
Early-stage specialists sourcing from French research institutes.
Global leader in Microbiome investments ("Health for Life").
Angel syndicate propelling health tech startups with expertise.
Healthtech-focused pre-seed and seed investor.
Leading pan-European VC for life sciences.
Independent VC with consumer/digital health focus.
Impact VC backing purpose-driven founders (Health & Wellbeing).
Focus on medical devices and digital health in Europe.
Healthtech specialist backing mission-driven founders.
Nordic VC firm and advisory specialist in early-stage medical devices.
Corporate Venture arm of Zambon (Pharma).
Investment company focused on Life Sciences & Medtech.
Operational holding company investing in MedTech.
Early-stage VC investing in digital transformation of legacy industries.
Technology-intensive VC with industrial approach.
"Primo Health" is their dedicated vehicle for healthcare.
Leading Italian VC dedicated to Life Sciences.
Impact investor with strong health track.
VC arm of Intesa Sanpaolo Group.
Venture Capital chaired by Stefano Buono, backed by foundations.
Asset management & Private Banking with VC arm ("Kairos Ventures").
Italian VC fund backed entirely by founders.
Established Italian VC with strong history in medtech/cardio.
Largest independent Italian VC. Strong biotech/pharma division.
VC focused on deep tech and tech transfer from universities.
European life sciences VC. Offices in Dublin, Paris, Milan.
Ireland’s largest dedicated life science VC.
Healthtech Venture Builder creating new businesses in future healthcare.
Early-stage VC investing in product-focused medical companies.
Europe’s most active healthtech venture builder.
Long-term investor in healthcare and technology.
Early-stage investments in health & care, focusing on digital transformation.
Specialized investor with Venture & Growth (therapeutics) and PE strategies.
Top-tier European life sciences VC. Deep expertise in drug development.
Formerly LSP. One of Europe’s largest healthcare investors.
Leading Nordic life science fund manager.
Early-stage fund specializing in Life Science and Technology.
Healthcare investor focusing on Nordic companies that benefit society.
State-owned investment company. Largest investor in Norway.
PE/VC boosting Portuguese innovation with health focus.
Independent VC spinning out of academic collaboration.
Leading Portuguese VC investing in deep tech and healthtech.
Spain's largest specialized biotech VC.
Corporate VC of Werfen. Specialized in diagnostics.
Specialized VC at the intersection of healthcare and technology.
Focus on technology transfer from academia to market.
Hands-on investment firm focusing on Spanish life sciences.
Healthcare innovation across biopharma, medtech, and digital health.
Impact house with a dedicated Ventures strategy.
SMA invests in and develops game-changing medtech.
Leading investment syndicate in the Nordics focusing on life science.
Nolsterby Invest AB is a Stockholm-Uppsala-based family office founded in 2017.
Science-driven investor backed by Wallenberg Investments.
Evergreen VC backing Nordic breakthrough innovations.
Nordic healthcare investment firm focusing on long-term value creation.
Major family of VC funds in Europe, backed 100+ companies.
Deep tech and life science fund founded by serial entrepreneur Christer Fåhraeus.
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally. Flerie is based in Stockholm and London managing a portfolio of over 30 investments in Europe, Israel, and the US.
Nordic life sciences VC investing in private companies.
Femtech-focused venture builder and investor.
Listed investment firm (NGM:CARDEO) transforming Nordic research into companies.
Family office of the Leksell family (founders of Elekta).
Global oncology specialist investing in cancer therapies.
(Also known as 3B Future Health). Invests in early-stage oncology/rare disease.
Seed stage fund investing in "improbable" breakthroughs.
Listed healthcare company founding and building companies.
Transatlantic healthcare investor with distinct sector funds.
Deeply scientific investor backing therapeutic breakthroughs.
Pre-seed/seed life science investor; extends human life/health.
Transatlantic life sciences investor transforming great science into medicines.
Foundation supervising the Biomedical Tech Transfer Fund.
Italian VC focused on deep tech and health innovation.
Early-stage biotech VC, often acting as co-founder.
Corporate VC of Chiesi Farmaceutici. Strategic focus on rare diseases.
Italy’s National Innovation Fund. Massive supporter of Italian ecosystem.
Corporate VC of Angelini Industries transforming patient journeys.
Biotech/Medtech specialist established by former Genextra team.
360° investment partner for Nordic life science companies.
Investment company focusing on early-stage Technology and Life Science.
Specialized global healthcare fund (UCITS) investing in listed/private companies.
Family-owned investment company focusing on Scandinavian growth companies.